"The key to executing a successful multichannel campaign is to know your audience, help them rather than sell to them and create meaningful content that shares the brand story appropriately across channels."

Imports act to outsource inspections

Reps. John Dingell (D-MI), Frank Pallone (D-NJ) and Bart Stupak (D-MI), have introduced the "Food and Drug Import Safety Act of 2007" (HR 3610), which they say will dramatically improve the nation's system for ensuring the safety of imported food and drugs.

The bill would create a user fee on imported food and drug shipments, with the funds generated used to hire additional personnel to perform inspections at the US border and abroad as well as at FDA labs to increase analysis of food and drug imports.

Meanwhile, the FDA said in October that it is considering outsourcing some of its foreign inspections.

Without hinting what changes the agency might seek in its overhaul plan due in November, assistant commissioner for policy Jeffrey Shuren acknowledged that a third-party inspection program might be proposed.

If it does, it will be acting consistently with advice given to Congress by former FDA regulatory counsel and Office of Criminal Investigations special agent Benjamin England.

He testified that the agency “can do a far better job in picking up data that come to it from multiple different sources, including domestic inspections of imported products, foreign inspections, third parties.”

England said there are already many international third-party inspection companies that could help the FDA, such as Bureau Veritas, ITS and Intertech.

They should be factored into FDA's surveillance, backed up to be “a meaningful auditing process,” he said.

Next Article in Legal/Regulatory

Did you miss January's Top 40 Healthcare Transformers
issue? Read how these inventors, strategists, entrepreneurs and wonks are challenging, disrupting and otherwise transforming the healthcare business. And join us April 30 to honor them at the Transforming Healthcare Dinner. Click here.

President Barack Obama's recently unveiled Precision Medicine Initiative hopes to develop a new model of patient-driven research with the promise of accelerating biomedical discoveries and provide clinicians with new tools, ...